Outlook Wealth Advisors LLC Raises Stake in Agilent Technologies, Inc. (NYSE:A)

Outlook Wealth Advisors LLC raised its position in Agilent Technologies, Inc. (NYSE:A) by 8.4% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,219 shares of the medical research company’s stock after acquiring an additional 172 shares during the quarter. Outlook Wealth Advisors LLC’s holdings in Agilent Technologies were worth $288,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in A. Livelsberger Financial Advisory purchased a new stake in shares of Agilent Technologies during the 4th quarter worth approximately $26,000. VisionPoint Advisory Group LLC purchased a new stake in shares of Agilent Technologies during the 4th quarter worth approximately $29,000. Rise Advisors LLC lifted its position in shares of Agilent Technologies by 527.8% during the 1st quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock worth $33,000 after buying an additional 190 shares during the last quarter. YHB Investment Advisors Inc. purchased a new stake in shares of Agilent Technologies during the 1st quarter worth approximately $34,000. Finally, Riverview Trust Co acquired a new position in shares of Agilent Technologies in the 1st quarter valued at $41,000. Hedge funds and other institutional investors own 87.42% of the company’s stock.

Insider Buying and Selling at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $130.00, for a total transaction of $254,540.00. Following the completion of the transaction, the chief executive officer now directly owns 25,185 shares in the company, valued at approximately $3,274,050. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In other news, SVP Dominique Grau sold 15,000 shares of the stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the completion of the transaction, the senior vice president now directly owns 49,486 shares in the company, valued at approximately $6,595,494.08. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $130.00, for a total value of $254,540.00. Following the transaction, the chief executive officer now owns 25,185 shares in the company, valued at $3,274,050. The disclosure for this sale can be found here. Insiders sold 18,916 shares of company stock valued at $2,527,860 over the last 90 days. 0.33% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on A. Evercore ISI lifted their target price on shares of Agilent Technologies from $126.00 to $130.00 and gave the company an “in-line” rating in a report on Tuesday, July 2nd. JPMorgan Chase & Co. cut their target price on shares of Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating on the stock in a report on Thursday, May 30th. UBS Group dropped their price objective on shares of Agilent Technologies from $155.00 to $141.00 and set a “neutral” rating on the stock in a research note on Thursday, May 30th. Jefferies Financial Group reissued a “hold” rating and issued a $135.00 price objective (down from $152.00) on shares of Agilent Technologies in a research note on Monday, June 3rd. Finally, Stifel Nicolaus lowered their price target on shares of Agilent Technologies from $163.00 to $151.00 and set a “buy” rating on the stock in a research note on Thursday, May 30th. One research analyst has rated the stock with a sell rating, six have given a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $137.27.

Agilent Technologies Trading Up 0.1 %

A traded up $0.15 on Friday, reaching $140.04. 1,284,834 shares of the company’s stock were exchanged, compared to its average volume of 1,753,159. The company’s 50 day moving average is $133.32 and its 200-day moving average is $138.28. The company has a market cap of $40.86 billion, a price-to-earnings ratio of 33.11, a PEG ratio of 4.86 and a beta of 1.05. Agilent Technologies, Inc. has a twelve month low of $96.80 and a twelve month high of $155.35. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.64 and a current ratio of 2.15.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, May 29th. The medical research company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.03. The firm had revenue of $1.57 billion during the quarter, compared to the consensus estimate of $1.58 billion. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The company’s revenue was down 8.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.27 EPS. Equities analysts predict that Agilent Technologies, Inc. will post 5.24 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd were given a $0.236 dividend. This represents a $0.94 annualized dividend and a yield of 0.67%. The ex-dividend date of this dividend was Tuesday, July 2nd. Agilent Technologies’s dividend payout ratio (DPR) is 22.22%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.